2-(Trifluoromethyl)piperidine hydrochloride

Catalog No.: 
ACVEQH381
CAS No.: 
627533-08-8
Molecular Formula: 
C6H11ClF3N
Molecular Weight: 
189.61
2-(Trifluoromethyl)piperidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$108.00In stockInquiry
5g98%$388.00In stockInquiry
10g98%$656.00In stockInquiry
25g98%$1312.00InquiryInquiry
50g98%$1968.00InquiryInquiry
100g98%$3280.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Trifluoromethyl)piperidine hydrochloride
IUPAC Name2-(trifluoromethyl)piperidine hydrochloride
MDL No.MFCD14584429
Molecular FormulaC6H11ClF3N
Molecular Weight189.61
SMILESFC(C1NCCCC1)(F)F.[H]Cl
InChI KeyLUBQESPBTCELOM-UHFFFAOYSA-N
Synonym2-(TrifluoroMethyl)piperidine hydrochloride;2-(Trifluoromethyl)piperidine hydrochloride >=96.0%;Piperidine, 2-(trifluoromethyl)-, hydrochloride;2-(Trifluoromethyl)piperidine hydrochloride
CAS No.627533-08-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVEQH381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFGMR439 route compound structure diagram
    ACFGMR4391394040-82-4In Stock
  2. Then
  3. ACVEQH381 route product structure diagram
    ACVEQH381627533-08-8In Stock
Inquiry

2. ACVEQH381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVEQH381 route product structure diagram
    ACVEQH381627533-08-8In Stock
Inquiry

3. ACVEQH381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVEQH381 route product structure diagram
    ACVEQH381627533-08-8In Stock
Inquiry

Comments (0)